Circulating microglia-derived extracellular vesicles predict recovery after rehabilitation in stroke survivors

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Circulating microglia-derived extracellular vesicles, along with neuron-derived vesicles and specific inflammatory markers, were found to predict functional recovery in stroke survivors undergoing rehabilitation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

This paper studied whether circulating blood biomarkers could predict functional recovery in 30 sub-acute stroke survivors undergoing intensive rehabilitation, using serum measurements at admission (T0) and discharge (T1). Researchers used multiplex Surface Plasmon Resonance imaging to profile extracellular vesicles (EVs) carrying markers from brain (neurons, astrocytes, microglia) and non-brain sources, combined with cytokine and neurofilament assessments, and applied machine learning with cross-validation to predict T1 modified Barthel Index outcomes from T0 data. They found that higher IL-6 and neurofilament light chain at T0 related to worse residual disability at T1, while higher EV levels from neurons (CD171+) and microglia (CD11b+) and increased VEGF receptor expression on microglial EVs were associated with better recovery; conversely, higher TGF-β receptor expression on IB4+ EVs during the subacute phase was associated with greater stroke severity. The paper is centrally about biomarker predictors of post-stroke rehabilitation recovery, and it does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background Timely intensive rehabilitation is crucial to contrast the negative escalation of events that follow a stroke injury, to promote tissue regeneration, and to restore the physiological function. This study aimed to identify measurable blood biomarkers that could be predictive of functional recovery in stroke survivors. Methods 30 sub-acute stroke subjects were enrolled at Fondazione Don Carlo Gnocchi Onlus (Italy) during the observation prospective cohort study EXO4STROKE ( NCT05370105 ). Among the clinical scales used for patient profiling, modified Barthel Index (MBI) was considered as primary outcome for the evaluation of rehabilitation recovery. Cytokines, Neurofilaments and circulating Extracellular Vesicles (EVs) were evaluated in the serum of patients at admission (T0) and at discharge (T1) in intensive rehabilitation unit. The Surface Plasmon Resonance imaging (SPRi) technique was exploited to obtain a multiplexed analysis of circulating EVs from brain (neurons, astrocytes, microglia) and non-brain (endothelium, skeletal muscle and platelets) cells, and for the relative quantification of markers of pathological or regenerative processes. Machine learning-based analysis complemented the study by integrating statistically significant features in a cross-validated prediction model targeting functional recovery at T1 from T0 data. Results High serum levels of IL-6 and Neurofilament Light Chain at T0 were associated with higher residual disability (lower outcome) at T1. In contrast, elevated circulating levels of EVs from neurons (CD171+) and microglia (CD11b+) were associated with better recovery after rehabilitaion. Moreover, the overexpression of the VEGF receptor on microglial EVs (IB4+ and CD11b+), was associated with higher functional improvement. Alternatively, the overexpression of TGF-β receptor on IB4+ EVs during the subacute phase post-stroke was found associated with increased stroke severity. The MBI at T1 was predicted with a median [iqr] absolute error of 5.7[8.7] points. Conclusion This study identifies a panel of few circulating biomarkers associated to Evs able to objectively assess post-stroke status and predict functional recovery after rehabilitation.
Full text 4,317 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

Background Timely intensive rehabilitation is crucial to contrast the negative escalation of events that follow a stroke injury, to promote tissue regeneration, and to restore the physiological function. This study aimed to identify measurable blood biomarkers that could be predictive of functional recovery in stroke survivors.

Methods

30 sub-acute stroke subjects were enrolled at Fondazione Don Carlo Gnocchi Onlus (Italy) during the observation prospective cohort study EXO4STROKE (NCT05370105). Among the clinical scales used for patient profiling, modified Barthel Index (MBI) was considered as primary outcome for the evaluation of rehabilitation recovery. Cytokines, Neurofilaments and circulating Extracellular Vesicles (EVs) were evaluated in the serum of patients at admission (T0) and at discharge (T1) in intensive rehabilitation unit. The Surface Plasmon Resonance imaging (SPRi) technique was exploited to obtain a multiplexed analysis of circulating EVs from brain (neurons, astrocytes, microglia) and non-brain (endothelium, skeletal muscle and platelets) cells, and for the relative quantification of markers of pathological or regenerative processes. Machine learning-based analysis complemented the study by integrating statistically significant features in a cross-validated prediction model targeting functional recovery at T1 from T0 data.

Results

High serum levels of IL-6 and Neurofilament Light Chain at T0 were associated with higher residual disability (lower outcome) at T1. In contrast, elevated circulating levels of EVs from neurons (CD171+) and microglia (CD11b+) were associated with better recovery after rehabilitaion. Moreover, the overexpression of the VEGF receptor on microglial EVs (IB4+ and CD11b+), was associated with higher functional improvement. Alternatively, the overexpression of TGF-β receptor on IB4+ EVs during the subacute phase post-stroke was found associated with increased stroke severity. The MBI at T1 was predicted with a median [iqr] absolute error of 5.7[8.7] points.

Conclusion

This study identifies a panel of few circulating biomarkers associated to Evs able to objectively assess post-stroke status and predict functional recovery after rehabilitation. Competing Interest Statement The authors have declared no competing interest. Clinical Trial NCT05370105 Funding Statement This project was supported by the Italian Ministry of Health, Ricerca Corrente and Conto Capitale 2020-2022 to Fondazione Don Carlo Gnocchi. This study was funded by ?5xMille funds-2022-Italian Ministry of Health? through the competitive grant ?Bando per la Valorizzazione della Ricerca Interna? of Fondazione Don Carlo Gnocchi ONLUS. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The present study was approved by the Ethical Committee of Fondazione Don Carlo Gnocchi Onlus ((protocol number: 20/2018/CE_FdG/FC/SA).), and carried out according to the Declaration of Helsinki. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00